Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Anticoagulant Activity of Naja nigricollis Venom Is Mediated by Phospholipase A2 Toxins and Inhibited by Varespladib
Taline D. Kazandjian, Arif Arrahman, Kristina B. M. Still, et al.
Toxins (2021) Vol. 13, Iss. 5, pp. 302-302
Open Access | Times Cited: 24

Showing 24 citing articles:

Varespladib in the Treatment of Snakebite Envenoming: Development History and Preclinical Evidence Supporting Advancement to Clinical Trials in Patients Bitten by Venomous Snakes
Matthew R. Lewin, Rebecca W. Carter, Isabel A. Matteo, et al.
Toxins (2022) Vol. 14, Iss. 11, pp. 783-783
Open Access | Times Cited: 43
Dermonecrosis caused by a spitting cobra snakebite results from toxin potentiation and is prevented by the repurposed drug varespladib
Keirah E. Bartlett, Steven R. Hall, Sean A. Rasmussen, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 19
Open Access | Times Cited: 9
Genetic variability in snake venom and its implications for antivenom development in sub-Saharan Africa
Innocent Ayesiga, Lenz Nwachinemere Okoro, Chirigo Taremba, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene (2025)
Closed Access | Times Cited: 1
In vitro and in vivo preclinical venom inhibition assays identify metalloproteinase inhibiting drugs as potential future treatments for snakebite envenoming by Dispholidus typus
Stefanie K. Menzies, Rachel H. Clare, Chunfang Xie, et al.
Toxicon X (2022) Vol. 14, pp. 100118-100118
Open Access | Times Cited: 21
Unraveling snake venom phospholipase A2: an overview of its structure, pharmacology, and inhibitors
Ganesh H. Sampat, Kashinath Hiremath, Jagadeesh Dodakallanavar, et al.
Pharmacological Reports (2023) Vol. 75, Iss. 6, pp. 1454-1473
Closed Access | Times Cited: 12
Rattlesnake Roundup: Point-of-Care Thrombelastographic Methods Define the Molecular Impacts on Coagulation of Crotalus Venom Toxins In Vitro and In Vivo
Vance G. Nielsen
Toxins (2025) Vol. 17, Iss. 2, pp. 87-87
Open Access
Enhancing Snakebite Management: The Role of Small Molecule Therapeutics in Complementing Antivenom Strategies
Grasiela Mariano Silva, Abhinandan Chowdhury
Toxicon (2024) Vol. 249, pp. 108081-108081
Closed Access | Times Cited: 3
The Relative Efficacy of Chemically Diverse Small-Molecule Enzyme-Inhibitors Against Anticoagulant Activities of African Spitting Cobra (Naja Species) Venoms
Abhinandan Chowdhury, Matthew R. Lewin, Christina N. Zdenek, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 23
Action of Varespladib (LY-315920), a Phospholipase A2 Inhibitor, on the Enzymatic, Coagulant and Haemorrhagic Activities of Lachesis muta rhombeata (South-American Bushmaster) Venom
Pamella G. Gutierres, Diego Roberto Pereira, Nataly L. Vieira, et al.
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 13
Single‐Batch Expression of an Experimental Recombinant Snakebite Antivenom Based on an Oligoclonal Mixture of Human Monoclonal Antibodies
Anna Christina Adams, Lise Marie Grav, Shirin Ahmadi, et al.
Biotechnology Journal (2024) Vol. 19, Iss. 10
Open Access | Times Cited: 2
Compendium of medically important snakes, venom activity and clinical presentations in Ghana
Justus P. Deikumah, Robert Peter Biney, John Koku Awoonor‐Williams, et al.
PLoS neglected tropical diseases (2023) Vol. 17, Iss. 7, pp. e0011050-e0011050
Open Access | Times Cited: 6
Phospholipase A2 inhibitor varespladib prevents wasp sting-induced nephrotoxicity in rats
Rui Wang, Dan Gao, Fanglin Yu, et al.
Toxicon (2022) Vol. 215, pp. 69-76
Closed Access | Times Cited: 8
A Combined Bioassay and Nanofractionation Approach to Investigate the Anticoagulant Toxins of Mamba and Cobra Venoms and Their Inhibition by Varespladib
Arif Arrahman, Taline D. Kazandjian, Kristina B. M. Still, et al.
Toxins (2022) Vol. 14, Iss. 11, pp. 736-736
Open Access | Times Cited: 7
Partial efficacy of a Brazilian coralsnake antivenom and varespladib in neutralizing distinct toxic effects induced by sublethal Micrurus dumerilii carinicauda envenoming in rats
Rosimeire Silva-Carvalho, Matheus Z. Gaspar, Luiz H.B. Quadros, et al.
Toxicon (2022) Vol. 213, pp. 99-104
Closed Access | Times Cited: 6
In Vitro Anti-Venom Potentials of Aqueous Extract and Oils of Toona ciliata M. Roem against Cobra Venom and Chemical Constituents of Oils
David Fred Okot, Jane Namukobe, Patrick Vudriko, et al.
Molecules (2023) Vol. 28, Iss. 7, pp. 3089-3089
Open Access | Times Cited: 2
Dermonecrosis caused by spitting cobra snakebite results from toxin potentiation and is prevented by the repurposed drug varespladib
Keirah E. Bartlett, Steven R. Hall, Sean A. Rasmussen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
The relative efficacy of chemically diverse small-molecule enzyme-inhibitors against anticoagulant activities of Black Snake (Pseudechis spp.) venoms
Abhinandan Chowdhury, Nicholas J. Youngman, Jiaojiao Liu, et al.
Toxicology Letters (2022) Vol. 366, pp. 26-32
Closed Access | Times Cited: 4
Clinical study of anti-snake venom blockade in the treatment of local tissue necrosis caused by Chinese cobra (Naja atra) bites
Linsheng Zeng, Jingjing Hou, Cuihong Ge, et al.
PLoS neglected tropical diseases (2022) Vol. 16, Iss. 12, pp. e0010997-e0010997
Open Access | Times Cited: 3
A Journey Along the Boulevard of Bioactive Compounds from Natural Sources, with Cosmetic and Pharmaceutical Potential: Bee Venom, Cobra Venom, Ficus carica
Monica Dinu, Carmen Galea, Ana Maria Chirilov, et al.
Cosmetics (2024) Vol. 11, Iss. 6, pp. 195-195
Open Access
Analysis and Identification of Putative Novel Peptides Purified from Iranian Endemic Echis Carinatus Sochureki Snake Venom by MALDI-TOF Mass Spectrometry

Archives of Razi Institute (2023), pp. 1503-1527
Open Access | Times Cited: 1
Analysis and Identification of Putative Novel Peptides Purified from Iranian Endemic
Nasri Nasrabadi Nafiseh, Vatanpour Hossein, Mohammadpour Dounighi Nasser, et al.
PubMed (2023) Vol. 78, Iss. 5, pp. 1503-1527
Closed Access | Times Cited: 1
Cardiac Effects of Micrurus corallinus and Micrurus dumerilii carinicauda (Elapidae) Venoms and Neutralization by Brazilian Coralsnake Antivenom and Varespladib
Matheus Z. Gaspar, Ana C. Yabunaka, Rosimeire Silva-Carvalho, et al.
Cardiovascular Toxicology (2023)
Closed Access
Snake venom phospholipases A2 and their roles in snakebite envenomings
Jaime Andres Pereáñez Jiménez
Elsevier eBooks (2023), pp. 105-123
Closed Access
In vitro and in vivo venom-inhibition assays identify metalloproteinase-inhibiting drugs as potential treatments for snakebite envenoming by Dispholidus typus
Stefanie K. Menzies, Rachel H. Clare, Chunfang Xie, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Page 1

Scroll to top